Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI)

Table 3

Performance of imaging modalities for detecting residual tumor after NAC.

	Sensitivity	Specificity	PPV	NPV	AUC
FFDM	76%	62.5%	86.4%	45.4%	0.8
CEM	76%	87.5%	95%	53.8%	0.8
MRI	92%	75%	92%	75%	0.9

NAC: neoadjuvant chemotherapy; PPV: positive predictive value; NPV: negative predictive value; AUC: area under the receiver operator characteristic curve; FFDM: full-field digital mammography; CEM: contrast-enhanced mammography; MRI: magnetic resonance imaging.